August 8, 2019
SNMMI’s Outreach Domain held a Dinner Symposium on “Incorporating New Approaches for Diagnosis and Treatment of Neuroendocrine Tumors,” July 30 in Houston, Texas, as part of our SNMMI Outreach Roadshow series. This event shared the latest developments for NETs with about 30 oncologists, gastroenterologists, and other referring physicians. Speakers were from the MD Anderson Cancer Center and included Homer Macapinlac, MD, Chair, Department of Nuclear Medicine; Gera Santiago, Nuclear Medicine Technologist; Beth Chasen, MD, Associate Professor of Nuclear Medicine; Daniel M. Halperin, MD, Assistant Professor of Gastrointestinal Medical Oncology; and Matthew Katz, MD, Hematology/Surgical Oncology. This past membership year, SNMMI has conducted more than 10 Outreach Roadshows to educate patients and referring physicians on nuclear medicine and molecular imaging developments. These events are currently focused on lymphoscintigraphy and the diagnosis and treatment of NETs, with an additional set of roadshows for DaT SPECT for Parkinson's Disease under development for 2020.
The SNMMI Outreach program is supported by our dedicated member volunteers through numerous working groups—including the Brain Imaging Working Group, Prostate Cancer Working Group, Targeted Radioisotope Therapy Working Group, and Practice-Based Outreach Working Group—as well as our Patient Advocacy Advisory Board. For more information on future SNMMI Outreach Roadshows, check the SNMMI 2019 Roadshow Schedule.
Speakers, left to right:
Homer Macapinlac, MD, Gera Santiago, Beth Chasen, MD, Daniel M. Halperin, MD, and Matthew Katz, MD.